Connect with us

Technology

Celebrating the Winners of the Inaugural Sony Women in Technology Award with Nature

Published

on

NEW YORK and LONDON and BERLIN and TOKYO, Feb. 4, 2025 /PRNewswire/ — Sony Group Corporation (Sony) and Nature are proud to announce the inaugural recipients of the Sony Women in Technology Award with Nature, honoring outstanding early to mid-career women researchers who are spearheading breakthroughs for the betterment of society and the planet in the field of technology (science, engineering, and mathematics). The award grants each winner a prize of $250,000 to support and accelerate their technological research.

The three winners Dr. Kiana Aran (UC San Diego, USA), Dr. Amanda Randles (Duke University, USA), and Dr. Yating Wan (King Abdullah University of Science and Technology, Saudi Arabia) as well as the Judges’ Commendation honoree Dr. Jiawen Li (University of Adelaide, Australia) were recognized today at an award ceremony in Tokyo, Japan.

Mid-Career Winners

Dr. Kiana Aran was selected for her achievements in the field of bioengineering. Aran is investigating the use of fingertip sensors for viral detection, exploring how artificial intelligence can work with advanced sensor technology to analyze multiple biomarkers and enable early detection of cancer and age-associated neurological diseases.

Aran, a professor of bioengineering and medicine at UC San Diego, is best known for pioneering work in the fusion of biology with electronics to enhance precision medicine. Among her achievements is the development of a CRISPR-powered electronic chip made from graphene, designed for the rapid detection of genetic diseases and respiratory infections such as COVID-19.

Beyond her research and entrepreneurial ventures, Aran is a vocal advocate for elevating the role of women in technology and leadership through her involvement with multiple organizations including New Voices for National Academies of Science, Engineering and Medicine. She has also established a non-profit organization dedicated to mentoring women engineers and actively promotes international scientific collaboration to foster a more inclusive and innovative future in the high-tech sector.

The judging panel noted that, “Aran’s achievements and vision in the field of bioengineering are impressive with a clear pathway to significant real-world impact for patients.” Aran’s aspiration to be a role model in the semiconductors area, where the representation of women is notably low, was well received by the panel.

Dr. Amanda Randles received the award for her innovative research in “digital twin” technology, which integrates wearable-informed computational models to provide personalized insights into cardiovascular hemodynamics and optimize treatment strategies.

Randles, a computational scientist and biomedical engineer, leads the Randles Lab at Duke University and is known for her contributions to high performance computing, machine learning, and the personalized modeling for disease diagnostics and treatment.

After successfully exploring the use of digital twin technology to guide interventions for heart patients, Randles and team are investigating how this technique can be applied to early intervention for cancer. With this prize, the Randles Lab plans to explore innovative ways of modeling and identifying new therapeutic targets to advance cancer treatment.

Speaking on their decision, the judging panel highlighted that Randles has a “significant impact opportunity in the fascinating space of digital twins,” and that, “her vision of a doctor reviewing digital twin organs to enable proactive intervention is inspiring.”

Early-Career Winner

Dr. Yating Wan won this year’s early career prize for her work in Silicon Photonics. Her research focuses on integrating light sources onto silicon chips for more energy-efficient data communication and information processing.

Leading the Integrated Photonics Lab at King Abdullah University of Science and Technology, Dr. Wan is recognized for her novel integration of ‘quantum dot’ lasers — nanocrystals made from semi-conductor materials — with silicon photonics, demonstrating important progress toward commercial use of photonic chips. With tech industry collaborators working on the same goals, her team is exploring how to deploy the chips in practical, real-world applications, such as optical datacom, sensing, and AI.

Commenting on their decision to award Wan the Early Career prize, the judging panel highlighted that as a rising star in her field, Wan is making “significant contributions to future of data communications and carries potential to revolutionize the future of silicon photonic sensors.”

Judges’ Commendation Recipient 

After receiving high-caliber applications from researchers worldwide, the judges’ panel decided to extend a special Judges’ Commendation to Dr. Jiawen Li, whose ambitious vision in the medical imaging field holds promise to improve healthcare globally. Li’s work combines nanoscale 3D printing with optical fiber technology to create a hair-thin endoscope that cardiologists can use to investigate blood vessels to determine a patient’s risk for a heart attack. This invention can also be used for prevention and personalized treatments.

Li, a biomedical engineer and Associate Professor at the University of Adelaide, Australia, is actively working on commercializing this invention, an important step in bringing this life-saving device to clinical practice. Together with her collaborators, Li is also expanding the multimodal technology’s features to measure data like site-specific temperature and chemical changes, as well as exploring applications in neurology and IVF.

“We launched this award in March 2024 with the clear aim of supporting more diverse gender representation within the international research community,” says Hiroaki Kitano, CTO of Sony Group Corporation and executive sponsor of the program. “We are very inspired by our honorees, each of them challenging the current state of the art in their fields. We look forward to championing their work, as well as growing the program in the years to come.”

Magdalena Skipper, Editor-in-Chief, Nature added:

“Women make up less than a third of the world’s workforce in technology related fields. However, the diversity, creativity, and innovation that women bring to research and technology is essential if we hope to address the most pressing challenges facing the world. Therefore, it is with great pride that we celebrate the inspiring work of Kiana Aran, Amanda Randles and Yating Wan. Through their commitment to scientific excellence and advocating for women in STEM, this year’s winners stand as perfect examples of role models for the next generation of women considering careers in research and engineering.”

Applications for the next cycle of the Sony Women in Technology Award with Nature open on March 6, 2025. To read more about eligibility guidelines, visit https://womenintechnology.sony.com/. To receive a reminder when the next application cycle launches, sign up for the Sony Women in Technology with Nature newsletter: https://natureresearch.formstack.com/forms/women_in_technology_award 

About Sony Group Corporation
Sony Group Corporation is a creative entertainment company with a solid foundation of technology. Across its six business segments – Game & Network Services; Music; Pictures; Entertainment, Technology & Services; Imaging & Sensing Solutions; and Financial Services – Sony’s purpose is to fill the world with emotion through the power of creativity and technology. For more information, visit:
https://www.sony.com/en/

About Nature Portfolio
Nature Portfolio’s high-quality products and services across the life, physical, chemical and applied sciences is dedicated to serving the scientific community. Nature (founded in 1869) is the leading, international weekly journal of science.

Nature Portfolio is also home to the Nature research and Nature Reviews journals, the leading open access multidisciplinary journal Nature Communications, and open access journals including Scientific Reports. Together, these journals publish some of the world’s most significant scientific discoveries.

Online, nature.com provides over nine million unique visitors per month with Nature Portfolio content, including news and comment from Nature, and the leading scientific jobs board, Nature Careers. Nature Portfolio also offers a range of researcher services, including online and in-person training and expert language and editing services. For more information, please visit nature.com and follow @NaturePortfolio. Nature Portfolio is part of Springer Nature.

About Springer Nature
Springer Nature is one of the leading publishers of research in the world. We publish the largest number of journals and books and are a pioneer in open research. Through our leading brands, trusted for more than 180 years, we provide technology-enabled products, platforms and services that help researchers to uncover new ideas and share their discoveries, health professionals to stay at the forefront of medical science, and educators to advance learning. We are proud to be part of progress, working together with the communities we serve to share knowledge and bring greater understanding to the world. For more information, please visit springernature.com and @SpringerNature.

View original content to download multimedia:https://www.prnewswire.com/news-releases/celebrating-the-winners-of-the-inaugural-sony-women-in-technology-award-with-nature-302368210.html

SOURCE Sony Group Corporation

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MATSON ANNOUNCES ADDITION OF 3 MILLION SHARES TO EXISTING SHARE REPURCHASE PROGRAM AND QUARTERLY DIVIDEND OF $0.36 PER SHARE

Published

on

By

HONOLULU, April 23, 2026 /PRNewswire/ — The Board of Directors of Matson, Inc. (NYSE: MATX), a leading U.S. carrier in the Pacific, approved adding three million shares to its existing share repurchase program and extending the program to December 31, 2029.  As of April 23, 2026, the existing share repurchase program had approximately 0.7 million shares remaining.  The Board also declared a second quarter dividend of $0.36 per common share.  The dividend will be paid on June 4, 2026 to all shareholders of record as of the close of business on May 7, 2026.

“We are pleased to announce an additional three million shares to our existing share repurchase program,” said Matt Cox, Matson’s Chairman and Chief Executive Officer.  “Since we commenced our share repurchase program in August 2021, we have repurchased approximately 14.3 million shares, or approximately 33% of the then outstanding shares, for a total cost of $1.3 billion.  Going forward, we will continue to be both disciplined and opportunistic in our capital allocation, and we remain committed to returning excess cash to shareholders to create additional shareholder value over the long-term.” 

Shares will be repurchased in the open market from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its common shares and general market conditions.  The Company may enter into Rule 10b5-1 plans to facilitate purchases under the program.  The repurchase program may be suspended or discontinued at any time.

About the Company

Founded in 1882, Matson (NYSE: MATX) is a leading provider of ocean transportation and logistics services.  Matson provides a vital lifeline of ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, and Guam, and to other island economies in Micronesia.  Matson also operates premium, expedited services from China to Long Beach, California, which includes cargo from other Asia origins, provides services to Okinawa, Japan and various islands in the South Pacific, and operates an international export service from Alaska to Asia.  The Company’s fleet of owned and chartered vessels includes containerships, combination container and roll-on/roll-off ships and barges.  Matson Logistics, established in 1987, extends the geographic reach of Matson’s transportation network throughout North America and Asia.  Its integrated logistics services include rail intermodal, highway brokerage, warehousing, freight consolidation, supply chain management, and freight forwarding to Alaska.  Additional information about the Company is available at www.matson.com.

Forward Looking Statements

Statements in this news release that are not historical facts are “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties that could cause actual results to differ materially from those contemplated by the relevant forward-looking statement, including but not limited to, statements about capital allocation plans, the timing, manner and volume of repurchases of common shares pursuant to the repurchase program, and use of excess cash.  These forward-looking statements are not guarantees of future performance.  This release should be read in conjunction with our Annual Report on Form 10-K and our other filings with the SEC through the date of this release, which identify important factors that could affect the forward-looking statements in this release.  We do not undertake any obligation to update our forward-looking statements.

View original content to download multimedia:https://www.prnewswire.com/news-releases/matson-announces-addition-of-3-million-shares-to-existing-share-repurchase-program-and-quarterly-dividend-of-0-36-per-share-302752377.html

SOURCE Matson, Inc.

Continue Reading

Technology

Accord Specialty Pharmacy Named Finalist in MMIT’s 11th Annual Retail Specialty Pharmacy Patient Choice Awards

Published

on

By

ORLANDO, Fla., April 23, 2026 /PRNewswire/ — Accord Specialty Pharmacy, an independent specialty pharmacy serving patients across multiple states, has been named a finalist in the MMIT Patient Choice Awards, a recognition based on patient-reported satisfaction and experience.

Accord was selected as the only independent pharmacy among finalists in its category, alongside national pharmacy organizations such as Walgreens Specialty Pharmacy and Walmart Specialty Pharmacy. This distinction highlights the company’s commitment to delivering personalized, high-touch care for patients managing complex and chronic conditions.

The MMIT Patient Choice Awards recognize specialty pharmacies that demonstrate excellence in patient satisfaction, service quality, and overall care experience. Finalists are determined based on direct patient feedback, making the recognition a meaningful reflection of the trust patients place in their pharmacy providers.

“Being recognized alongside national organizations and as the only independent finalist validates our belief that personalized, patient-centered care drives better outcomes. We are building a model that combines clinical depth, national reach, and operational flexibility to better serve patients, providers, and partners.” said AJ Patel, Founder and Pharmacy Manager of Accord Specialty Pharmacy.

Accord Specialty Pharmacy supports patients across complex specialty categories, including oncology, rare disease, and infusion, through a clinically driven, high-touch care model designed to improve access, adherence, and outcomes. The company’s approach emphasizes personalized support, responsive care coordination, and strong clinical engagement to help patients navigate complex therapies more effectively. With a growing national footprint and multi-state licensure, Accord is positioned to support patients, providers, and partners across diverse markets.

For more information, visit MMIT Announces Finalists of the 11th Specialty Pharmacy Patient Choice Awards – MMITNetwork.

About Accord Specialty Pharmacy:

Accord Specialty Pharmacy is an ACHC-accredited, multi-state licensed independent specialty pharmacy located in Central Florida, dedicated to delivering high-quality, patient-centered care for individuals managing complex and chronic conditions. Through personalized support, clinical expertise, and a high-touch approach, Accord helps patients navigate every step of their treatment journey. Learn more at www.accordspecialty.com.

CONTACT: contact@accordspecialty.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accord-specialty-pharmacy-named-finalist-in-mmits-11th-annual-retail-specialty-pharmacy-patient-choice-awards-302752327.html

SOURCE Accord Specialty

Continue Reading

Technology

HAIVISION ANNOUNCES VOTING RESULTS FROM 2026 ANNUAL MEETING OF SHAREHOLDERS

Published

on

By

MONTRÉAL, April 23, 2026 /CNW/ – Haivision Systems Inc. (“Haivision” or the “Company”) (TSX: HAI) is pleased to announce the voting results from its annual meeting of shareholders held today in a virtual format.

A total of approximately 45.97 % of the issued and outstanding common shares of Haivision were represented at the meeting.

Election of Directors

Each of the six nominated directors of Haivision was elected as director of the Company with the following results:

Director

Votes
For

% Votes
For

Votes
Against

% Votes
Against

Miroslav Wicha

11,110,245

99.26 %

82,583

0.74 %

Harvey Bienenstock

11,155,137

99.66 %

37,691

0.34 %

Robin M. Rush

11,121,855

99.37 %

70,973

0.63 %

Neil Hindle

10,794,005

96.44 %

398,823

3.56 %

Julie Tremblay

10,941,969

97.76 %

250,859

2.24 %

Lee K. Levy II

9,084,418

81.16 %

2,108,410

18.84 %

2.   Appointment of Auditors

Deloitte LLP were reappointed auditors of the Company for the ensuing year with 12,492,582 (98.84%) votes cast in favour and 146,406 (1.16%) votes withheld.

3.   Approval of the Unallocated Awards under the Company’s Equity Incentive Plan

The Company’s unallocated awards were approved with 8,710,347 (77.82%) votes cast in favour and 2,482,481 (22.18%) votes cast against.

4.   Reapproval of Company’s Shareholder Rights Plan

The Company’s shareholder rights plan was approved with 10,572,490 (94.46%) votes cast in favour and 620,338 (5.54%) votes cast against.

Final voting results on all matters voted on at the meeting will be filed under Haivision’s profile on SEDAR+ at www.sedarplus.ca.

About Haivision

Haivision is a leading global provider of mission-critical, real-time video streaming and visual collaboration solutions. Our connected cloud and intelligent edge technologies enable organizations globally to engage audiences, enhance collaboration, and support decision making. We provide high quality, low latency, secure, and reliable live video at a global scale. Haivision open sourced its award-winning SRT low latency video streaming protocol and founded the SRT Alliance to support its adoption. Awarded four Emmys® for Technology and Engineering from the National Academy of Television Arts and Sciences, Haivision continues to fuel the future of IP video transformation. Founded in 2004, Haivision is headquartered in Montreal and Chicago with offices, sales, and support located throughout the Americas, Europe, and Asia. Learn more at haivision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/haivision-announces-voting-results-from-2026-annual-meeting-of-shareholders-302752318.html

SOURCE Haivision Systems Inc.

Continue Reading

Trending